{"disease":{"id":"mta","name":"mta"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07063745","title":"A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":590,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06914128","title":"A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":370,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06188702","title":"S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":342,"lead_sponsor_name":"Servier Bio-Innovation LLC","has_results":false},{"nct_id":"NCT05094336","title":"A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":329,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT06130553","title":"A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":234,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06593522","title":"A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT06928818","title":"Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT07312539","title":"Risk Factors on the Long-Term Success of Mineral Trioxide Aggregate Pulpotomy","phase":"","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Sümeyra Akkoç","has_results":false},{"nct_id":"NCT06796699","title":"A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Suzhou Genhouse Bio Co., Ltd.","has_results":false},{"nct_id":"NCT07283705","title":"A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07311902","title":"M-Tapa Block and Transversus Abdominal Plane Block for Postoperative Analgesia in Unilateral Open Inguinal Hernia Repair Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Erzurum Regional Training & Research Hospital","has_results":false},{"nct_id":"NCT05975073","title":"A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":53,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT06125834","title":"Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT06683833","title":"Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT06568614","title":"An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":29,"lead_sponsor_name":"BeOne Medicines","has_results":false},{"nct_id":"NCT06433375","title":"Evaluation of the Efficacy of Growth Hormone, EndoSeal MTA Sealer, and Their Combination on Healing of Periapical Pathosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Al-Azhar University","has_results":false},{"nct_id":"NCT03437655","title":"Influence of the Composition of Temporary Restorative Material in Vital Teeth","phase":"NA","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Federal University of Uberlandia","has_results":false},{"nct_id":"NCT03437629","title":"Influences of Different Temporary Cement on Retention Rate of Temporary Crowns","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Federal University of Uberlandia","has_results":false},{"nct_id":"NCT03488316","title":"Influence of Temporary Filling Material Composition on the Success Rate of Endodontic Treatments","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"PAULO VINICIUS SOARES","has_results":false},{"nct_id":"NCT03491527","title":"Influence of Resin Cement Composition on the Longevity of Intraradicular Post of Endodontically Treated Teeth","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Federal University of Uberlandia","has_results":false},{"nct_id":"NCT03744793","title":"Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":18,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06672523","title":"A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":8,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}